Literature DB >> 8995534

Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells.

R Newton1, L M Kuitert, D M Slater, I M Adcock, P J Barnes.   

Abstract

Prostaglandin (PG) release, which is increased in vivo by inflammatory conditions and in vitro by pro-inflammatory cytokines, is decreased by glucocorticoids. Two phospholipase A2 isoforms, secretory (sPLA2) and cytosolic (cPLA2,), have been implicated in inflammation. These enzymes catalyse the release of arachidonic acid which is then converted to prostaglandins by the cyclooxygenases (COX-1 and COX-2). Regulation of these events at the mRNA level is poorly characterised in epithelial cells. We have used a human epithelial-like cell line (A549) as a model system to study mRNA expression of sPLA2, cPLA2, COX-1 and COX-2. Following treatment of cells and extraction of RNA, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to examine expression of these genes. We show a coordinate induction of both cPLA2 and COX-2 mRNA by pro-inflammatory cytokines which correlated with increased PGE2 release. By contrast, sPLA2 mRNA was undetectable and COX-1 was found to be expressed at a constant low level. In addition dexamethasone pretreatment significantly reduced both cPLA2 and COX-2 mRNA levels as well as PGE2 release following cytokine stimulation. These data indicate a major role for control of prostaglandin synthesis at the mRNA level of key synthetic genes in epithelial cells. Furthermore we show that a major mechanism of glucocorticoid action in preventing prostaglandin release occurs by suppression of cPLA2 and COX-2 mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995534     DOI: 10.1016/s0024-3205(96)00590-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  22 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

3.  Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

Authors:  M Lasa; M Brook; J Saklatvala; A R Clark
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids.

Authors:  P O Cover; D Slater; J C Buckingham
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

5.  The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.

Authors:  R Newton; L Cambridge; L A Hart; D A Stevens; M A Lindsay; P J Barnes
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment.

Authors:  A E Redington; Q H Meng; D R Springall; T J Evans; C Créminon; J Maclouf; S T Holgate; P H Howarth; J M Polak
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

7.  Hyperoxia and interferon-γ-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway.

Authors:  Rayman Choo-Wing; Mansoor A Syed; Anantha Harijith; Brianne Bowen; Gloria Pryhuber; Cecilia Janér; Sture Andersson; Robert J Homer; Vineet Bhandari
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

8.  Nuclear factor-kappaB does not mediate the inhibitory effects of dexamethasone on granulocyte-macrophage colony-stimulating factor expression.

Authors:  Martin W Bergmann; Karl J Staples; Peter J Barnes; Robert Newton
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

9.  Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone.

Authors:  Karl J Staples; Martin W Bergmann; Peter J Barnes; Robert Newton
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

Review 10.  The mechanism and mitigation of niacin-induced flushing.

Authors:  V S Kamanna; S H Ganji; M L Kashyap
Journal:  Int J Clin Pract       Date:  2009-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.